JPS6352639B2 - - Google Patents
Info
- Publication number
- JPS6352639B2 JPS6352639B2 JP9354480A JP9354480A JPS6352639B2 JP S6352639 B2 JPS6352639 B2 JP S6352639B2 JP 9354480 A JP9354480 A JP 9354480A JP 9354480 A JP9354480 A JP 9354480A JP S6352639 B2 JPS6352639 B2 JP S6352639B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- chloroform
- methanol
- added
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000284 extract Substances 0.000 claims description 55
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 claims description 4
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 3
- -1 aliphatic ester Chemical class 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 75
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 70
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 43
- 239000000203 mixture Substances 0.000 description 27
- 239000007788 liquid Substances 0.000 description 22
- 238000000605 extraction Methods 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 15
- 238000010828 elution Methods 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 7
- 238000010908 decantation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 238000004305 normal phase HPLC Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000011894 semi-preparative HPLC Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 241000208327 Apocynaceae Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- SGDAJMSNTKLPML-SKMKETMKSA-N Condurangogenin A Chemical compound O([C@@H]1[C@H]([C@@H]2[C@@]3(C)CC[C@H](O)C[C@@H]3CC[C@H]2[C@@]2(O)CC[C@@H]([C@]21C)C(C)=O)OC(=O)C)C(=O)\C=C\C1=CC=CC=C1 SGDAJMSNTKLPML-SKMKETMKSA-N 0.000 description 1
- NUPFZNSJJIZBGR-DSXGPZHDSA-N Condurangogenin C Chemical compound O([C@@H]1[C@@H](OC(C)=O)[C@@H]2[C@@]3(C)CC[C@H](O)C[C@@H]3CC[C@H]2[C@@]2(O)CC[C@@H]([C@@]12C)C(O)C)C(=O)\C=C\C1=CC=CC=C1 NUPFZNSJJIZBGR-DSXGPZHDSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241001347462 Marsdenia cundurango Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229930191727 condurangogenin Natural products 0.000 description 1
- FKXVPEBFIHNLPS-UHFFFAOYSA-N condurangogenin C Natural products CC(=O)OC1C2(C)C(C(O)C)CCC2(O)C2CCC3CC(O)CCC3(C)C2C1OC(=O)C=CC1=CC=CC=C1 FKXVPEBFIHNLPS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9354480A JPS5718700A (en) | 1980-07-09 | 1980-07-09 | 20-o-methyl-condurango glycoside do, its preparation, and antitumor agent comprising it |
| IT8167295A IT1144136B (it) | 1980-03-05 | 1981-03-03 | Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione |
| BE0/204013A BE887793A (fr) | 1980-03-05 | 1981-03-04 | Nouveaux condurango-glycosides, agents antitumeurs en comprenant et procede pour les preparer |
| NL8120043A NL8120043A (nl) | 1980-03-05 | 1981-03-05 | Nieuwe condurango glycoside-verbindingen, werkwijze voor de bereiding hiervan, anti-tumormiddelen die deze stoffen omvatten en samenstellingen, die deze middelen bevatten. |
| CH7326/81A CH647533A5 (de) | 1980-03-05 | 1981-03-05 | Cundurango-glycosid-verbindungen, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende tumorbekaempfende mittel. |
| PCT/JP1981/000045 WO1981002577A1 (en) | 1980-03-05 | 1981-03-05 | Novel cundurango glycosides,process for their preparation,antineoplastic agent,and composition containing same |
| AU67800/81A AU6780081A (en) | 1980-03-05 | 1981-03-05 | Novel cundurango glycosides, process for their preparation, antineoplastic agent, and composition containing same |
| CA000372389A CA1169852A (en) | 1980-03-05 | 1981-03-05 | Condurango glycoside compounds, antitumor agents comprising them and processes for their preparation |
| US06/320,974 US4452786A (en) | 1980-03-05 | 1981-03-05 | Condurango glycoside compounds, processes for their preparation, antitumor agents comprising them and compositions |
| EP19810900551 EP0054570A4 (en) | 1980-03-05 | 1981-03-05 | NOVEL CONDURANGO GLYCOSIDES, PROCESS FOR THE PREPARATION THEREOF, ANTINEOPLAST AGENTS, AND COMPOSITION CONTAINING THE SAME. |
| DE19813137612 DE3137612A1 (de) | 1980-03-05 | 1981-03-05 | Novel cundurango glycosides,process for their preparation,antineoplastic agent,and composition containing same |
| GB8209580A GB2093032B (en) | 1980-03-05 | 1981-03-05 | Novel condurango glycosides process for their preparation antineoplastic agent and composition containing same |
| SE8202140A SE8202140L (sv) | 1980-03-05 | 1982-04-02 | Nya condurango-glykosidforeningar, forfarande for deras framstellning, antitumormedel som omfattar dem och kompositioner der de ingar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9354480A JPS5718700A (en) | 1980-07-09 | 1980-07-09 | 20-o-methyl-condurango glycoside do, its preparation, and antitumor agent comprising it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5718700A JPS5718700A (en) | 1982-01-30 |
| JPS6352639B2 true JPS6352639B2 (enrdf_load_stackoverflow) | 1988-10-19 |
Family
ID=14085203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9354480A Granted JPS5718700A (en) | 1980-03-05 | 1980-07-09 | 20-o-methyl-condurango glycoside do, its preparation, and antitumor agent comprising it |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5718700A (enrdf_load_stackoverflow) |
-
1980
- 1980-07-09 JP JP9354480A patent/JPS5718700A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5718700A (en) | 1982-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6059237B2 (ja) | シソ科植物からの有効物質 | |
| GB2024622A (en) | Anti-psoriatic fern extracts | |
| DE69406430T2 (de) | Alkaloide von Mappie foetida, deren Anwendung und diese enthaltende Zusammensetzungen | |
| JP3128823B2 (ja) | 制癌化合物およびその製造法 | |
| JPS6352639B2 (enrdf_load_stackoverflow) | ||
| JPS6352638B2 (enrdf_load_stackoverflow) | ||
| WO2024216818A1 (zh) | 一种异海松烷型二萜类化合物及其制备方法和应用 | |
| Ahmed et al. | A contribution to the chemistry and toxicology of the root of Pbytolacca americana, L. | |
| FI64892C (fi) | Foerfarande foer framstaellning av en terpenblandning med antipsoriatisk effekt | |
| US4452786A (en) | Condurango glycoside compounds, processes for their preparation, antitumor agents comprising them and compositions | |
| PL100003B1 (pl) | Sposob oczyszczania ekstraktow zawierajacych substancje dzialajaca oczyszczajaco na macice | |
| JPS6354000B2 (enrdf_load_stackoverflow) | ||
| JPH0234957B2 (ja) | Konzurangohaitotai*sonoseizohohooyobisorekaranarukoshuyozai | |
| CN111170967A (zh) | 酰基间苯三酚类衍生物及其药物组合物和应用 | |
| JPS6251277B2 (enrdf_load_stackoverflow) | ||
| US4320119A (en) | Extracts of Marsdenia cundurango Reichenbach fil | |
| JPS6256160B2 (enrdf_load_stackoverflow) | ||
| EP0541780A1 (en) | VEGETABLE ANTINEOPLASTIC CHEMOTHERAPEUTIC, WITH HIGH SELECTIVITY AND VERY REDUCED TOXICITY, AND METHOD FOR THE PRODUCTION THEREOF. | |
| IE54425B1 (en) | A process for obtaining laxative compounds from senna drug | |
| CN109180632A (zh) | 一种从雷公藤中分离出的新化合物及其制备方法和医药用途 | |
| CA1144917A (en) | Extracts of marsdenia cundurango reichenbach fil | |
| US4740521A (en) | Saudin, a novel hypoglycemic agent | |
| JPS6153330B2 (enrdf_load_stackoverflow) | ||
| JP2541272B2 (ja) | 悪液質治療剤 | |
| JP2000302784A (ja) | アポシニン類およびそれらを含有する肝疾患予防・治療剤 |